BRCA Within Gene Large Rearrangement (LR)

Large genomic rearrangements affecting one or more exons account for approximately 5~10% of all disease-causing mutations in BRCA1 and BRCA2 genes in patients with hereditary breast and ovarian cancer syndrome. DRAGEN LR can detect within gene large genomic rearrangements in tumor-only mode for whole-exome sequencing (WES) and targeted panels. The performance has been verified with TruSight Oncology 500 Assay.